Harmony Biosciences Holdings (HRMY) Total Liabilities (2019 - 2026)

Harmony Biosciences Holdings' Total Liabilities history runs 8 years deep, the most recent figure standing at $361.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 7.9% year-over-year to $361.5 million; the TTM figure through Mar 2026 stood at $361.5 million (up 7.9% YoY), while the FY2025 annual figure was $401.4 million, up 18.05% from the prior year.
• Total Liabilities came in at $361.5 million for Q1 2026 at Harmony Biosciences Holdings, down from $401.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $401.4 million in Q4 2025 to a low of $249.5 million in Q1 2022.
• A 5-year average of $317.4 million and a median of $331.3 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities grew 27.09% in 2023 and decreased 1.28% in 2024, its largest moves.
• Harmony Biosciences Holdings' Total Liabilities stood at $271.0 million in 2022, then advanced by 27.09% to $344.5 million in 2023, then fell by 1.28% to $340.0 million in 2024, then grew by 18.05% to $401.4 million in 2025, then fell by 9.95% to $361.5 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $361.5 million, $401.4 million, and $373.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison